You are here

legal

Gilead settles with US government in long-running patent dust-up over PrEP meds Truvada, Descovy

Fierce Pharma

Thu, 01/16/25 - 11:08 am

Gilead Sciences

Pfizer appeals denial of $75 million claim in SEC case against Cohen hedge fund

Yahoo/Reuters

Tue, 01/14/25 - 06:10 pm

Novartis's U.S. patent for Entresto upheld by appeals court

Marketscreener

Mon, 01/13/25 - 05:45 pm

Purdue's Sacklers offer to increase contribution in new opioid settlement, WSJ reports

US News and World Report

Mon, 01/13/25 - 11:15 am

BioNTech inks settlements with NIH, UPenn in COVID-19 vaccine royalty disputes

Fierce Pharma

Sun, 01/5/25 - 09:35 pm

Abbott, Dexcom settle glucose monitor patent lawsuits

Medtech Dive

Fri, 01/3/25 - 10:48 am

Lilly asks to join GLP-1 compounding lawsuit

BioSpace

Fri, 01/3/25 - 10:47 am

compounded drugs

US accuses CVS of filling, billing government for illegal opioid prescriptions

MSN/Reuters

Wed, 12/18/24 - 07:46 pm

Sandoz shells out $275M in latest effort to move past 'legacy' price-fixing litigation

Fierce Pharma

Tue, 12/17/24 - 12:03 pm

McKinsey & Company to pay $650 million to settle opioid consulting probe, ex-partner to plead guilty

CNBC

Fri, 12/13/24 - 11:45 am

Jury convicts ex-CytoDyn CEO on 9 counts tied to biotech fraud

Fierce Biotech

Wed, 12/11/24 - 11:02 am

Insulin pump firm Insulet wins $452m in trade secrets clash

Pharmaphorum

Fri, 12/6/24 - 09:07 am

Novartis bid to block generic Entresto in US suffers setback

Pharmaphorum

Thu, 12/5/24 - 11:01 am

BMS files legal challenge to HHS' 340B rebate decision

Pharmaphorum

Mon, 12/2/24 - 10:17 am

Bristol Myers Squibb

As J&J tries to wrap up talc litigation in the US, the company now faces class action in UK

Fierce Pharma

Fri, 11/22/24 - 11:51 am

McKinsey nears deferred prosecution pact in US opioid probe, sources say

Yahoo/Reuters

Thu, 11/21/24 - 10:48 pm

Pfizer loses bid to recoup $75 million left over from SEC settlement

MSN/Reuters

Tue, 11/19/24 - 07:19 pm

insider trading

Lilly sues US agency over blocking of drug-rebate program

MSN/Reuters

Fri, 11/15/24 - 11:08 am

Bristol Myers faces renewed, $6.7 billion lawsuit over delayed cancer drug

Yahoo/Reuters

Thu, 11/14/24 - 11:06 pm

Bristol Myers Squibb

Johnson & Johnson Takes the 340B Drug Rebate Fight to Federal Court

MedCity News

Wed, 11/13/24 - 09:48 pm

Pages